Iterative Health
Caitlyn Seidl, BS, CCRP, serves as the VP of Clinical, Regulatory and Scientific Affairs at Iterative Health since July 2023 and is the Owner of Seidl Solutions, LLC, providing consulting services in clinical and regulatory strategies for the Medical Device community. Prior roles include Vice President of Clinical Affairs at Motus GI Holdings, Sr. Manager of Clinical Affairs at Medtronic, and Director of Clinical Affairs at Medical Components, Inc., where significant contributions included clinical strategies for product development, EU MDR compliance, clinical evaluation report development, and post-market surveillance. Caitlyn's extensive experience encompasses leadership roles at Edwards Lifesciences and Stryker, focusing on clinical study strategy, regulatory submissions, and KOL engagement. Educationally, Caitlyn holds a BS in Biomedical Sciences from the University of South Florida.
This person is not in any teams
This person is not in any offices
Iterative Health
1 followers
Iterative Health is pioneering the use of artificial intelligence-based precision medicine in gastroenterology (GI), with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD). We use advanced machine learning and computer vision to interpret endoscopic images along with other types of data, helping clinicians to better assess patients with potential GI problems. This gives practitioners enhanced capabilities in the detection, annotation, disease scoring and treatment of GI related diseases. Iterative Health is initially applying these advances towards standardizing disease severity characterization for inflammatory bowel disease. Ultimately, the company aims to establish more meaningful endpoints to serve as better predictors of both therapeutic response and disease outcomes. The company is headquartered in Cambridge, Massachusetts.
Employees
51-200